The diverse analyst opinions and the reduction in the average price target could lead to short-term uncertainty in XOMA's stock price. However, the company's positive revenue growth and financial performance metrics, such as a high net margin and ROA, provide a solid foundation that may mitigate any negative impacts. The high debt-to-equity ratio and below-average ROE are concerns, but the overall financial health as indicated by revenue growth and profitability metrics could maintain investor interest.